Maywufa Company Ltd. (TPE:1731)
20.70
0.00 (0.00%)
Aug 19, 2026, 1:30 PM CST
Maywufa Company Revenue
Maywufa Company had revenue of 402.15M TWD in the quarter ending June 30, 2026, with 7.34% growth. This brings the company's revenue in the last twelve months to 1.64B, up 7.65% year-over-year. In the year 2025, Maywufa Company had annual revenue of 1.58B with 6.61% growth.
Revenue (ttm)
1.64B
Revenue Growth
+7.65%
P/S Ratio
1.68
Revenue / Employee
7.33M
Employees
224
Market Cap
2.75B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.58B | 98.19M | 6.61% |
| Dec 31, 2024 | 1.49B | 185.15M | 14.23% |
| Dec 31, 2023 | 1.30B | 55.62M | 4.47% |
| Dec 31, 2022 | 1.25B | -44.11M | -3.42% |
| Dec 31, 2021 | 1.29B | 223.89M | 21.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Orient EuroPharma | 4.59B |
| Panion & Bf Biotech | 2.11B |
| TSH Biopharm Corporation | 1.40B |
| Allied Biotech | 922.49M |
| Easywell Biomedicals | 799.94M |
| Tien Liang BioTech | 650.87M |
| Johnson Chemical Pharmaceutical Works | 569.57M |
| LIWANLI Innovation | 414.67M |